The Latest: Pfizer modifies protocol for virus vaccine study
NEW YORK - Drugmaker Pfizer has again modified the protocol for its late-stage study of its vaccine against the new coronavirus, this time to include more young participants. |!| P…
NEW YORK - Drugmaker Pfizer has again modified the protocol for its late-stage study of its vaccine against the new coronavirus, this time to include more young participants. |!| P…